Genetic analysis and midline malignancies of uncertain origin

Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer.

Investigational new drugs·1998

Phase I trial of extracellular adenosine 5'-triphosphate in patients with advanced cancer.

Medical and pediatric oncology·1996

Clinical use of tumor markers in oncology.

Current problems in cancer·1991

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

Cancer·1989

Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer.

Cancer·1988

Non-small cell lung cancer.

Disease-a-month : DM·1988

Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.

Journal of the National Cancer Institute·2026

Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.

Journal of the National Cancer Institute·2026

Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib.

Journal of the National Cancer Institute·2026

Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.

Journal of the National Cancer Institute·2026

Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan.

Journal of the National Cancer Institute·2026

Examining the role of extrachromosomal DNA in lung cancer.

Journal of the National Cancer Institute·2026

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

British journal of haematology·2026

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

British journal of haematology·2026

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance.

Cancer cytopathology·2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Haematologica·2026

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Haematologica·2026

Related Experiment Videos

Genetic analysis and midline malignancies of uncertain origin

Related Concept Videos

Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer.

Phase I trial of extracellular adenosine 5'-triphosphate in patients with advanced cancer.

Clinical use of tumor markers in oncology.

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer.

Non-small cell lung cancer.

Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.

Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.

Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib.

Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.

Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan.

Examining the role of extrachromosomal DNA in lung cancer.

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance.

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Related Experiment Videos

Genetic analysis and midline malignancies of uncertain origin

Related Concept Videos

Related Articles